Cases 21 - 30 of 457
BAUSCH & LOMB INCORPORATED et al v. LUPIN LTD. et al
as 2:2023cv02664
Plaintiff:
BAUSCH & LOMB INCORPORATED and BAUSCH + LOMB IRELAND LIMITED
Defendant:
LUPIN LTD., LUPIN ATLANTIS HOLDINGS SA, LUPIN INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BRAINTREE LABORATORIES, INC. et al v. LUPIN LIMITED et al
as 2:2023cv02853
Plaintiff:
BRAINTREE LABORATORIES, INC. and SEBELA US INC.
Defendant:
LUPIN LIMITED, LUPIN PHARMACEUTICALS, INC. and LUPIN INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Gilead Sciences, Inc. et al v. Lupin Limited et al
as 1:2023cv00508
Plaintiff:
Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P. and others
Defendant:
Lupin Limited, Lupin Pharmaceuticals, Inc., MSN Laboratories Private Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In re Novartis and Par Antitrust Litigation
as 1:2018cv04361
Defendant:
Endo Pharmaceuticals, Inc., Par Pharmaceutical, Inc., Novartis Pharmaceuticals Corporation and others
Plaintiff:
Drogueria Betances, LLC, H-E-B LP, Rite Aid Hdqtrs. Corp., and others
Consolidated Plaintiff:
Law Enforcement Health Benefits Inc., Turlock Irrigation District and UFCW Local 1500 Welfare Fund
Respondent:
Mylan Pharmaceuticals, Inc.
Not Classified By Court:
Lupin Ltd., Lupin Pharmaceuticals, Inc., OptumRX, Inc. and others
Interested Party:
Caremark PHC, LLC and Mylan Pharmaceuticals Inc.
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation (Monopolizing Trade)
Catalyst Pharmaceuticals, Inc. et al v. Lupin Ltd. et al
as 1:2023cv00229
Plaintiff:
Catalyst Pharmaceuticals, Inc. and SERB SA
Defendant:
Lupin Ltd., Lupin Inc. and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
CATALYST PHARMACEUTICALS, INC. et al v. LUPIN LTD. et al
as 2:2023cv01197
Plaintiff:
CATALYST PHARMACEUTICALS, INC. and SERB SA
Defendant:
LUPIN LTD., LUPIN INC. and LUPIN PHARMACEUTICALS, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. et al v. Alkem Laboratories Limited et al
as 1:2022cv01423
Plaintiff:
AbbVie Inc., AbbVie Ltd. and Neurocrine Biosciences, Inc.
Defendant:
Alkem Laboratories Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Amicus Therapeutics US, LLC et al v. Lupin Ltd. et al
as 1:2022cv01465
Plaintiff:
Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc.
Defendant:
Lupin Ltd., Lupin Pharmaceuticals, Inc. and Springcare USA LLC doing business as Spring Bio Solution
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Louisiana v. AbbVie Inc et al
as 6:2023cv00225
Plaintiff:
State of Louisiana
Defendant:
AbbVie Inc, Warner Chilcott Sales U S L L C, Warner Chilcott, Ltd and others
Cause Of Action: 28 U.S.C. § 1331 Fed. Question: Anti-trust
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al
as 1:2023cv00926
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
